Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Ordinary shares, par value $0.0135 per share
-
Shares outstanding
-
3.32M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
140K
-
Shares change
-
+140K
-
Total reported value, excl. options
-
$281K
-
Value change
-
+$281K
-
Number of buys
-
3
-
Price
-
$2.01
Significant Holders of Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) as of Q4 2024
3 filings reported holding SLXN - Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share as of Q4 2024.
Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 140K shares
of 3.32M outstanding shares and own 4.22% of the company stock.
Largest 3 shareholders include Wildcat Capital Management, LLC (113K shares), UBS Group AG (14.9K shares), and HRT FINANCIAL LP (11.9K shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.